Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01088867 · ClinicalTrials.gov registry record · NA

Using Diffuse Noxious Inhibitory Control (DNIC) to Predict Acupuncture Therapy Outcome: A Pilot Study

A NA study, sponsored by University of Washington.

Completed
Registry status
NA
Development phase
10
Enrollment target

NCT01088867: Completed NA study, sponsored by University of Washington.

NCT01088867 is a NA study that has completed, run by University of Washington. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01088867, a NA study, has completed, sponsored by University of Washington.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target

Study Summary

The investigators hypothesize that acupuncture modifies the DNIC efficiency and that DNIC can serve as a predictor to identify 'good responders' to acupuncture early in therapy.

Primary Outcome

The efficiency of diffuse noxious inhibitory control (DNIC) is a measure of one's ability to inhibit pain perception. DNIC efficiency is assessed by a psychophysical test that involves a heat thermode as the "test stimulus" and a warm water bath as the "conditioning stimulus". The results of this test will be used as the primary outcome measure.

Interventions

  • OTHER Acupuncture

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2010-03
Est. Completion 2010-07
Phase NA
University of Washington

1,048 total trials

What the finished NCT01088867 record still lists

NCT01088867 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Acupuncture is the first listed.

NCT01088867 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01088867 about?

NCT01088867 is a clinical study titled "Using Diffuse Noxious Inhibitory Control (DNIC) to Predict Acupuncture Therapy Outcome: A Pilot Study". The investigators hypothesize that acupuncture modifies the DNIC efficiency and that DNIC can serve as a predictor to identify 'good responders' to acupuncture early in therapy.

What is the current status of trial NCT01088867?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2010-03. Estimated completion is 2010-07.

What interventions are being tested in trial NCT01088867?

The interventions under investigation include: Acupuncture (OTHER).

Who is sponsoring clinical trial NCT01088867?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01088867's enrollment target sits among peer trials

10 1927th of 2000 higher than 26 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01088867, the US trial registry maintained by the National Library of Medicine. NCT01088867 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.